Medication adherence issues in patients: focus on cost

References

• Bonaccorso S. Perspectives from the pharmaceutical industry. BMJ. 2003;327(7419):863–864.
   Google Scholar
• Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
   Web of Science ®Google Scholar
• Tebbi CK. Treatment compliance in childhood and adolescence. Cancer. 1993;71(Suppl 10):S344–S3449.
   Web of Science ®Google Scholar
• World Health Organization. Adherence to long-term therapies–Evidence for action [online]. Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Accessed November 7, 2012.
   Google Scholar
• Tilson HH. Adherence or compliance: changes in terminology. Ann Pharmacother. 2004;38(1):161–162.
   Web of Science ®Google Scholar
• Vrijens B, De Geest B, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.
   PubMed Web of Science ®Google Scholar
• Fischer MA, Stedman MR, Lii J, et al. Primary medication nonadherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284–290.
   PubMed Web of Science ®Google Scholar
• Pullar T. Compliance with drug therapy. Br J Clin Pharmacol. 1991; 32(5):535–539.
   Web of Science ®Google Scholar
• Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Int Med. 1990;150(7):1377–1378.
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR. Variations in patients’ adherence to medical recommendations–A quantitative review of 50 years of research. Med Care. 2004;42(3):200–209.
   PubMed Web of Science ®Google Scholar
• Foulon V, Schöffski P, Wolter P. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clinica Belgica. 2011;66(2):85–96.
   Web of Science ®Google Scholar
• Kondryn HJ, Edmondson CL, Hill J, Eden TO. Treatment nonadherence in teenage and young adult patients with cancer. Lancet Oncol. 2011;12(1):100–108.
   PubMed Web of Science ®Google Scholar
• Butow P, Palmer S, Pai A, Goodenough B, Luckett T, King M. Review of adherence-related issues in adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4800–4809.
   PubMed Web of Science ®Google Scholar
• Germani G, Lazzaro S, Gnoato F, et al. Nonadherent behaviors after solid organ transplantation. Transplant Proc. 2011;43(1):318–323.
   Web of Science ®Google Scholar
• Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83(7):858–873.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes–A meta-analysis. Med Care. 2002;40(9):794–811.
   PubMed Web of Science ®Google Scholar
• Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol. 2002;109(Suppl 6):S554–S559.
   Web of Science ®Google Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–1310.
   PubMed Web of Science ®Google Scholar
• Coleman CI, Limone B, Sobieraj DM, et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm. 2012;18(7): 527–539.
   PubMed Web of Science ®Google Scholar
• Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care. 2009;15(6):e22–e33.
   PubMed Web of Science ®Google Scholar
• McNicholas F. To adhere or not, and what we can do to help. Eur Child Adolesc Psychiatry. 2012;21(12):657–663.
   PubMed Web of Science ®Google Scholar
• Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs. 1995;49(3):321–327.
   PubMed Web of Science ®Google Scholar
• Ingerski LM, Hente EA, Modi AC, Hommel KA. Electronic measurement of medication adherence in pediatric chronic illness: a review of measures. J Pediatr. 2011;159(4):528–534.
   PubMed Web of Science ®Google Scholar
• Mahtani KR, Heneghan CJ, Glasziou PP, Perara R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2011;9:CD005025.
   Google Scholar
• Nevin TE. “Why do they do that?” The compliance conundrum. Pediatr Nephrol. 2005;20(7):845–848.
   Web of Science ®Google Scholar
• Urquhart J. Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J. 1996;17(Suppl A): 8–15.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713–719.
   PubMed Web of Science ®Google Scholar
• Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326(7404):1419.
   PubMed Web of Science ®Google Scholar
• Wald NJ, Wald DS. The polypill concept. Heart. 2010;96(1):1–4.
   Google Scholar
• Granger BB, Bosworth HB. Medication adherence: emerging use of technology. Curr Opin Cardiol 2011;26(4):279–287.
   Web of Science ®Google Scholar
• Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–795.
   PubMed Web of Science ®Google Scholar
• Dean AJ, Walters J, Hall A. A systematic review of interventions to enhance medication adherence in children and adolescents with chronic illness. Arch Dis Child. 2010;95(9):717–723.
   PubMed Web of Science ®Google Scholar
• van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion. BMC Health Serv Res. 2008;8:47.
   PubMed Web of Science ®Google Scholar
• Hughes DA, Bagust A, Haycox A, Walley T. Accounting for noncompliance in pharmacoeconomic evaluations. Pharmacoeconomics. 2001; 19(12):1185–1197.
   Web of Science ®Google Scholar
• Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
   PubMed Web of Science ®Google Scholar
• Cleemput I, Kesteloot K, DeGeest S. A review of the literature on the economics of noncompliance. Room for methodological improvement. Health Policy. 2002;59(1):65–94.
   PubMed Web of Science ®Google Scholar
• Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842–1847.
   PubMedGoogle Scholar
• Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772–779.
   PubMed Web of Science ®Google Scholar
• Esposti LD, Saragoni S, Benemei S, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res. 2011;3:47–54.
   PubMedGoogle Scholar
• Simpson RJ Jr, Mendys P. The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review. J Clin Lipidol. 2010;4(6):462–471.
   Web of Science ®Google Scholar
• Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109.
   PubMed Web of Science ®Google Scholar
• Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841.
   PubMed Web of Science ®Google Scholar
• Williams LK, Peterson EL, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011;128(6):1185–1191.
   PubMed Web of Science ®Google Scholar
• Higgins PD, Rubin DT, Kaulback K, Schoenfield PS, Kane SV Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmcol Ther. 2009;29(3):247–257.
   PubMed Web of Science ®Google Scholar
• Dobbels F, Ruppar T, De Geest S, Decorte A, Van Damme-Lombaerts R, Fine RN. Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr Transplant. 2010;14(5):603–613.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Landier W, Shangguan M, et al. Nonadherence to oral mer-captopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children’s oncology group. J Clin Oncol. 2012;30(17):2094–2101.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.
   PubMed Web of Science ®Google Scholar
• Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146(8):564–573.
   PubMed Web of Science ®Google Scholar
• Morken G, Widen JH, Grawe RW. Non-adherence to antipsychotic medication, relapse and rehospitalization in recent-onset schizophrenia. BMC Psychiatry. 2008;8:32.
   PubMed Web of Science ®Google Scholar
• Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 2010;176(2–3):109–113.
   PubMed Web of Science ®Google Scholar
• Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63(2):136–147.
   PubMed Web of Science ®Google Scholar
• Leendertse AJ, Egberts AC, Stoker LK, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in The Netherlands. Arch Intern Med. 2008;168(17):1890–1896.
   PubMed Web of Science ®Google Scholar
• Easton KL, Parsons BJ, Starr M, Brien JE. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust. 1998;169(7):356–359.
   Web of Science ®Google Scholar
• Heisler M, Choi H, Rosen AB, et al. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care. 2010;48(2):87–94.
   PubMed Web of Science ®Google Scholar
• Ambardekar AV Fonarow GC, Hernandez AF, Pan W, Yancy CW, Kranz MJ. Characteristics and in-hospital outcomes for nonadherent patients with heart failure: finding from Get With The Guidelines-Heart Failure (GWTC-HF). Am Heart J. 2009;158(4):644–652.
   PubMed Web of Science ®Google Scholar
• Law MR, Soumerai SB, Ross-Degnan D, Adams AS. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry. 2008;69(1):47–53.
   PubMed Web of Science ®Google Scholar
• Dragomir A, Côté R, Roy L, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010;48(5):418–425.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11): 939–943.
   PubMed Web of Science ®Google Scholar
• Encinosa WE, Bernard D, Dor A. Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes. Adv Health Econ Health Serv Res. 2010;22:151–173.
   PubMedGoogle Scholar
• Kane SV, Chao J, Mulani PM. Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patients. Adv Ther. 2009;26(10):936–946.
   PubMed Web of Science ®Google Scholar
• Carter CT, Waters HC, Smith DB. Effect of a continuous measure of adherence with infliximab maintenance treatment on inpatient outcomes in Crohn’s disease. Patient Prefer Adherence. 2012;6:417–426.
   PubMed Web of Science ®Google Scholar
• Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011;30(1): 91–99.
   PubMed Web of Science ®Google Scholar
• New England Healthcare Institute. Thinking outside the pillbox – A system-wide approach to improving patient medication adherence for chronic disease. Aug 2009. Available from: http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_improving_patient_medication_adherence_for_chronic_disease. Accessed November 8, 2012.
   Google Scholar
• Hughes D. When drugs don’t work – Economic assessment of enhancing compliance with interventions supported by electronic monitoring devices. Pharmacoeconomics. 2007;25(8):621–635.
   Web of Science ®Google Scholar
• Hughes D, Cowell W, Koncz T, Cramer J. Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations. Value Health. 2007;10(6):498–509.
   PubMed Web of Science ®Google Scholar
• Hughes DA, Bagust A, Haycox A, Walley T. The impact of noncompliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ. 2001;10(7):601–615.
   Web of Science ®Google Scholar
• Hiligsmann M, Boonen A, Rabenda V, Reginster J. The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis. Expert Rev Pharmacoecon Outcomes Res. 2012;12(2):159–166.
   PubMed Web of Science ®Google Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–530.
   PubMed Web of Science ®Google Scholar
• Muszbek N, Brixner D, Benedict A, Keskinaslan A, Khan ZM. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. Int J Clin Pract. 2008;62(2):338–351.
   PubMed Web of Science ®Google Scholar
• Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35(12):2533–2539.
   PubMed Web of Science ®Google Scholar
• Breitscheidel L, Stamenitis S, Dippel FW, Schöffski O. Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper. J Med Econ. 2010;13(1):8–15.
   PubMedGoogle Scholar
• Adachi JD, Josse RG, Russell RG. If you don’t take – it can’t work: the consequences of not being treated or nonadherence to osteoporosis therapy. Ther Clin Risk Manag. 2011;7:181–198.
   PubMed Web of Science ®Google Scholar
• Hiligsmann M, Rabenda V, Bruyere O, Reginster J. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients. Health Policy. 2010;96(2):170–177.
   PubMed Web of Science ®Google Scholar
• Hovstadius B, Petersson G. Non-adherence to drug therapy and drug acquisition costs in a national population – a patient-based register study. BMC Health Serv Res. 2011;11:326.
   PubMed Web of Science ®Google Scholar
• Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost- related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864–871.
   PubMed Web of Science ®Google Scholar
• Laba TL, Brien JA, Jan S. Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia. BMC Fam Pract. 2012;13(1):61.
   Google Scholar
• Zheng B, Poulose A, Fulford M, Holbrook A. A pilot study on cost-related medication nonadherence in Ontario. J Popul Ther Clin Pharmacol. 2012;19(2):e239–e247.
   Google Scholar
• Law MR, Cheng L, Dhalla IA, Heard D, Morgan SG. The effect of cost on adherence to prescription medications in Canada. CMAJ. 2012;184(30):297–302.
   Google Scholar
• Kirking DM, Lee JA, Ellis JJ, Briesacher B, McKercher PL. Patient-reported underuse of prescription medications: a comparison of nine surveys. Med Care Res Rev. 2006;63(4):427–446.
   PubMed Web of Science ®Google Scholar
• Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing – Association with medication and medical utilization and spending and health. JAMA. 2007;298(1):61–69.
   PubMed Web of Science ®Google Scholar
• Eaddy MT, Cook CL, O’Day K, Burch SP, Cantrell R. How patient cost-sharing trends affect adherence and outcomes–A literature review. P T. 2012;37(l):45–55.
   Google Scholar
• Solomon MD, Goldman DP, Joyce GF, Escarce JJ. Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med. 2009;169(8):740–748.
   Google Scholar
• Wang V, Liu CF, Bryson CL, Sharp ND, Maciejewski ML. Does medication adherence following a copayment increase differ by disease burden? Health Serv Res. 2011;46(6 Pt 1):1963–1985.
   Web of Science ®Google Scholar
• Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–424.
   PubMed Web of Science ®Google Scholar
• M’Imunya JM, Kredo T, Volmink J. Patient education and counseling for promoting adherence to treatment for tuberculosis. Cochrane Database Syst Rev. 2012;5:CD006591.
   Google Scholar
• Van Servellen G, Heise BA, Ellis R. Factors associated with antidepressant medication adherence and adherence-enhancement programmes: a systematic literature review. Ment Health Fam Med. 2011;8(4):255–271.
   PubMedGoogle Scholar
• Elliot RA, Barber N, Home R. Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence. Ann Pharmacother. 2005;39(3):508–515.
   Web of Science ®Google Scholar
• Golay A. Pharmacoeconomic aspects of poor adherence: can better adherence reduce healthcare costs? J Med Econ. 2011;14(5):594–608.
   PubMedGoogle Scholar
• Patrick AR, Schousboe JT, Losina E, Solomon DH. The economics of improving medication adherence in osteoporosis: validation and application of a simulation model. J Clin Endocrinol Metab. 2011;96(9):2762–2770.
   Web of Science ®Google Scholar
• Ito K, Shrank WH, Avorn J, et al. Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. Health Serv Res. 2012;47(6):2097–2117.
   PubMed Web of Science ®Google Scholar
• Corrao G, Scotti L, Zambon A, et al. Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases. Atherosclerosis. 2011;217(2):479–485.
   Web of Science ®Google Scholar
• Chapman RH, Ferrufino CP, Kowal SL, Classi P, Roberts CS. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs. Int J Clin Pract. 2010;64(2): 169–181.
   PubMed Web of Science ®Google Scholar
• Chapman RH, Kowal SL, Cherry SB, Ferrufino CP, Roberts CS, Chen L. The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid- lowering medications. Value Health. 2010;13(6):685–694.
   PubMed Web of Science ®Google Scholar
• Gilden J, Staring ABP, van der Gaag M, Mulder CL. Does treatment adherence therapy reduce expense of healthcare use in patients with psychotic disorders? Cost-minimization analysis in a randomized controlled trial. Schizophr Res. 2011;133(1–3):47–53.
   Web of Science ®Google Scholar
• Farley JF, Wansink D, Lindquist JH, Parker JC, Maciejewski ML. Medication adherence changes following value-based insurance design. Am J Manag Care. 2012;18(5):265–274.
   PubMed Web of Science ®Google Scholar
• Encinosa WE. Value-based insurance design in Medicare. Appl Health Econ Health Policy. 2009;7(3):149–154.
   Google Scholar
• Melnick SJ, Motheral BR. Is “value-based” value wasted? Examining value-based insurance designs through the lens of cost-effectiveness. J Manag Care Pharm. 2010;16(2):130–133.
   Web of Science ®Google Scholar
• Choudhry NK, Rosenthal MB, Milstein A. Assessing the evidence for value-based insurance design. Health Aff (Millwood). 2010;29(11):1988–1994.
   Web of Science ®Google Scholar
• de Souza JA, Ratain MJ, Fendrick AM. Value-based insurance design: aligning incentives, benefits, and evidence in oncology. J Natl Compr Canc Netw. 2012;10(1):18–23.
   PubMed Web of Science ®Google Scholar
• Frank MD, Fendrick AM, He Y, et al. The effect of a large regional health plan’s value-based insurance design program on statin use. Med Care. 2012;50(11):934–939.
   PubMed Web of Science ®Google Scholar
• Choudhry NK, Fischer MA, Avorn JL, et al. The impact of reducing cardiovascular medication copayments on health spending and resource utilization. J Am Coll Cardiol. 2012;60(18):1817–1824.
   PubMed Web of Science ®Google Scholar
• Fendrick AM, Martin JJ, Weiss AE. Value-based insurance design: more health at any price. Health Serv Res. 2012;47(1 Pt 2): 404–413.
   Web of Science ®Google Scholar
• Zeng F, An JJ, Scully R, Barrington C, Patel BV, Nichol MB. The impact of a value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation. Value Health. 2010;13(6):846–852.
   PubMed Web of Science ®Google Scholar
• Fairman KA, Curtiss FR. What do we really know about VBID? Quality of the evidence and ethical considerations for health plan sponsors. J Manag Care Pharm. 2011;17(2):156–174.
   Web of Science ®Google Scholar
• Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125(9):888–896.
   Web of Science ®Google Scholar
• DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med. 2012;55 Suppl:S86-S94.
   Web of Science ®Google Scholar
• Burns T. Is it acceptable for people to be paid to adhere to medication? Yes. BMJ. 2007;335(7613):232.
   Google Scholar
• Shaw J. Is it acceptable for people to be paid to adhere to medication? No. BMJ. 2007;335(7613):233.
   Google Scholar